Long or short menstrual cycles linked to higher risk of CVD including atrial fibrillation

(Press-News.org) Research Highlights:

An analysis of data for more than 58,000 women in the U.K. Biobank found that both short (less than 21 days) or long (more than 35 days) menstrual cycles were associated with the development of cardiovascular disease, heart attack or atrial fibrillation (AFib). Short or long menstrual cycle length was associated with a 19% higher risk of heart disease among those women compared to women with menstrual cycle length between 22 to 34 days. Irregular menstrual cycle length was associated with a 40% higher risk of atrial fibrillation. Embargoed until 4 a.m. CT/5 a.m. ET Wednesday, May 24, 2023

DALLAS, May 24, 2023 — A study of more than 58,000 women over a 12-year period found that longer or shorter menstrual cycles were associated with a higher risk of developing cardiovascular disease, heart attack or atrial fibrillation (AFib), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

Regular menstrual cycle length, defined as cycle length between 22 and 34 days, throughout a woman’s reproductive life reflects normal functioning of the connected hormone systems among the hypothalamus, pituitary gland and ovaries and are a vital indicator of overall health. Irregular menstrual cycles are a common endocrine disorder, with about 20% of women experiencing long cycles or cycles of varying lengths, according to previous research.

Previous research has found that irregular menstrual cycles are significantly related to multiple heart disease risk factors, including insulin resistance, high cholesterol, high blood pressure, chronic inflammation and polycystic ovarian syndrome. Other studies have found that women are at higher risk for arrhythmias, or irregular heartbeats, due to hormonal fluctuations of the menstrual cycle.

“The association between menstrual cycle characteristics and adverse cardiovascular outcomes remains unclear,” said senior author Huijie Zhang, M.D., Ph.D., chief physician and professor at Nanfang Hospital of Southern Medical University in China. “Considering the increasing prevalence of heart disease — with 45% of women in Western countries affected — and related mortality, there is a need to explore these risk factors.”

Researchers analyzed data from the U.K. Biobank to investigate whether menstrual cycle length, which was self-reported, was associated with overall heart disease and specific cardiovascular events in women. The U.K. Biobank is a large database of health information for more than 500,000 adults – enrolled from 2006 until 2010 – who receive care through the United Kingdom’s National Health Service. This study included health data for 58,056 women with an average age of 46 years at the beginning of the study period, as well as no cardiovascular disease. Health data was collected through four follow-up visits that took place from 2006-2010, 2012-2013, and in 2014 and 2019. Participants with menopause when the study began were excluded. The end of the study period was November 30, 2020, the most recent date for health data available for this analysis.

During a median follow-up period of 12 years, more than 1,600 cardiovascular events were noted among the participants, including coronary heart disease, heart attack, atrial fibrillation, stroke or heart failure. The analysis found:

Menstrual cycles less than 21 days or longer than 35 days were associated with a 19% higher risk of heart disease among those women compared to the women with regular menstrual cycle length, defined by this study as between 22 to 34 days, as well as a 40% higher risk of atrial fibrillation. Shorter menstrual cycles were associated with a 29% higher risk of CVD events — including coronary heart disease, heart attack, atrial fibrillation, stroke and heart failure — and longer menstrual cycles were associated with an 11% higher risk of those CVD events, compared with regular-length menstrual cycles. Shorter menstrual cycles were associated with a 38% higher risk of atrial fibrillation, and longer menstrual cycles were associated with a 30% higher risk atrial fibrillation, compared with regular length menstrual cycles. Menstrual cycle length was not associated with an increased risk of stroke or heart failure. These increased risks of cardiovascular disease were observed in the women independent of other risk factors, including age, ethnicity, BMI or body mass index, smoking status, drinking status, physical activity, baseline cholesterol levels, history of high blood pressure or Type 2 diabetes, history of oral contraceptive use or hormone replacement therapy, and family history of heart disease or stroke.

“Our analysis indicates that women with menstrual cycle dysfunction may experience adverse cardiovascular health consequences, therefore, we need to raise awareness that individuals with irregular menstrual cycle patterns may be more likely to develop heart disease,” Zhang said. “These findings have important public health implications for the prevention of atrial fibrillation and heart attack among women and highlight the importance of monitoring menstrual cycle characteristics throughout a woman’s reproductive life.”

The study had several limitations including that its question about menstrual regularity relied on the participant’s interpretation of irregular menstrual cycle length. The researchers could not rule out the potential impact of menopausal transition on irregular menstrual cycles because participant data at younger ages and including hormone levels were not available. Additionally, the U.K. Biobank dataset is a population of older adults (ages 40-69 years), the majority of whom self-identified as white, meaning the findings may not be generalizable to women from diverse racial or ethnic backgrounds or younger women.

Co-authors are Chensihan Huang, M.D.; Bingquan Lin, M.D.; Youwen Yuan, M.D.; Kangli Li, M.D.; Bingyan Xu, M.D.; Peizhen Zhang, M.D.; Xueyun Wei, M.D.; Weiwei Wang, M.D.; Wenhui Liu, M.D.; Yajuan Deng, M.D.; Deying Liu, M.D.; Jiayang Lin, M.D.; and Yan Huang, M.S. Authors’ disclosures are listed in the manuscript.

This study was funded by the National Key Research and Development Project, National Natural Science Foundation of China, the Joint Funds of the National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, and the Key-Area Clinical Research Program of Southern Medical University.

Statements and conclusions of studies published in the American Heart Association’s scientific journals are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association’s overall financial information are available here.

Additional Resources:

Multimedia is available on the right column of release link https://newsroom.heart.org/news/long-or-short-menstrual-cycles-linked-to-higher-risk-of-cvd-including-atrial-fibrillation?preview=1b3a45204c7861a9d4318543fe0156b3 After May 24, view the manuscript online. AHA news release: Early menopause may raise risk of dementia later in life (March 2022) AHA news release: Early menopause linked to higher risk of future coronary heart disease (May 2021) AHA news release: Heart disease risk in women increases leading up to menopause; early intervention is key (Nov. 2020) Follow AHA/ASA news on Twitter @HeartNews Follow news from the Journal of the American Heart Association @JAHA_AHA About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

###

END